FamiCord AG
V3V
Company Profile
Business description
FamiCord AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of Cell & Gene therapies and CDMO. It continues to develop from a pure stem cell bank to a more broadly based cell bank that can supply the available patient’s own cells for current and future cell therapies.
Contact
Perlickstrase 5
LeipzigD-04103
DEUT: +49 3414879240
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
766
Stocks News & Analysis
stocks
10 US stocks with the largest fair value estimate increases during Q4 earnings
Semiconductor companies Sandisk, Teradyne, and Applied Materials saw the largest fair value hikes.
stocks
Berkshire Hathaway earnings: Cash hits record $373 billion on mostly solid results across the firm
We think Berkshire Hathaway stock is fairly valued.
stocks
Magellan Financial Group: A dilutive acquisition of Barrenjoey
Our view of the proposed merger.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,296.60 | 104.10 | -1.11% |
| CAC 40 | 8,394.32 | 186.43 | -2.17% |
| DAX 40 | 24,638.00 | 646.26 | -2.56% |
| Dow JONES (US) | 48,838.69 | 139.23 | -0.28% |
| FTSE 100 | 10,780.11 | 130.44 | -1.20% |
| HKSE | 26,112.40 | 52.55 | 0.20% |
| NASDAQ | 22,748.86 | 80.64 | 0.36% |
| Nikkei 225 | 56,727.27 | 1,329.97 | -2.29% |
| NZX 50 Index | 13,624.92 | 98.05 | -0.71% |
| S&P 500 | 6,875.63 | 3.25 | -0.05% |
| S&P/ASX 200 | 9,079.80 | 88.30 | -0.96% |
| SSE Composite Index | 4,161.79 | 20.80 | -0.50% |